2 min reading time

If you were asked to name a price at which you’d sell your company, could you do it? What can you do today to achieve the greatest enterprise value, even if you have no immediate plans to sell?

Dave Sheppard (formerly VP, Covidien) and Florence Joffroy-Black of MedWorld Advisors have developed an algorithm to assess enterprise value and, based on your outcome, can tell you which management decisions will add the most incremental value.

They’ll share the concept on a webinar designed for our Medical Devices Group on August 1. Sign up now at http://medgroup.biz/value for the free information.

Dave said, “Beyond increasing sales and reducing costs, we find few entrepreneurs know how to measure the financial impact of their management decisions. And still fewer are focused on enterprise value until they’re ready to sell – at which point they come to the market under-prepared and have to settle for a lower price (if they are saleable at all).”

Florence adds, “The strategies we teach are best executed well in advance of an actual sale. They also apply to distressed entities in a turnaround situation and in cases where the owner wants to take additional cash out of the business.”

Among the questions we’ll cover on the webinar are:
· What are the key factors and priorities to maximize the intrinsic value of your business?
· How to get your management team engaged focused on the right improvements?
· How to determine if you’re focusing on the right customers?
· What is the right type of growth for your specific situation?

I’m grateful having experts like Dave and Flo share their knowledge with the Group. Get the information by registering at http://medgroup.biz/value and we’ll send you the replay and downloadable slides whether you can attend live or not.

+++

Today’s webinar is about a QMS designed specifically for medical devices with speaker Jon Speer. Join us or get the slides later at http://medgroup.biz/greenlight.

+++

Joe Hage
Medical Devices Group Leader

---

Julie Omohundro
Principal Consultant at Class Three, LLC
This is a very interesting topic. Can anyone provide a reference to information on evaluation of the alternative strategy, which is to operate the company instead of selling it? It seems the ability to weigh the two becomes more and more useful as industry consolidation seems to be peaking.

Dave Sheppard, CMAA
Global M&A, OutSourced B,D&L Leader for SME (Small and Medium Enterprises) & Emerging Technology Healthcare Companies
Hi Julie – Great question! And the good news is that’s what professional M&A Advisors do – (like www.medworldadvisors.com). We will provide the independent financial analysis to help owners evaluate the objective evidence of the best timing of when to sell. Additionally, we will help evaluate if it’s a better fit for a P.E. firm or a strategic or other option. The biggest challenge is to help walk an owner thru the emotional process of when to sell – based on their own personal and professional needs. In other words, what does the “before and after” sale lifestyle look like for that business owner?

Katie Bates
CITO MEDICAL – Biotech & Medical Product Development
Thanks Joe!

Dr.Ravi Giri
Medical Doctor at Army Hospital, Nepal
Thanks

Caroline Keenan
Tax Director at ASM Chartered Accountants
Mm

Brandon Winn
Founder at Vessel Biosciences, LLC & Product Manager at Mealtime Microgreens
10% Equity 100k Google Drive